203 related articles for article (PubMed ID: 23103983)
1. Active self-healing encapsulation of vaccine antigens in PLGA microspheres.
Desai KG; Schwendeman SP
J Control Release; 2013 Jan; 165(1):62-74. PubMed ID: 23103983
[TBL] [Abstract][Full Text] [Related]
2. Gamma irradiation of active self-healing PLGA microspheres for efficient aqueous encapsulation of vaccine antigens.
Desai KG; Kadous S; Schwendeman SP
Pharm Res; 2013 Jul; 30(7):1768-78. PubMed ID: 23515830
[TBL] [Abstract][Full Text] [Related]
3. A biomimetic approach to active self-microencapsulation of proteins in PLGA.
Shah RB; Schwendeman SP
J Control Release; 2014 Dec; 196():60-70. PubMed ID: 25219750
[TBL] [Abstract][Full Text] [Related]
4. Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery.
Bailey BA; Desai KH; Ochyl LJ; Ciotti SM; Moon JJ; Schwendeman SP
Mol Pharm; 2017 Sep; 14(9):3228-3237. PubMed ID: 28726424
[TBL] [Abstract][Full Text] [Related]
5. Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation.
Hafner AM; Corthésy B; Textor M; Merkle HP
Int J Pharm; 2016 Nov; 514(1):176-188. PubMed ID: 27863662
[TBL] [Abstract][Full Text] [Related]
6. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of tetanus toxoid encapsulated in PLGA microspheres.
Jiang W; Schwendeman SP
Mol Pharm; 2008; 5(5):808-17. PubMed ID: 18710256
[TBL] [Abstract][Full Text] [Related]
8. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid.
Gupta RK; Chang AC; Griffin P; Rivera R; Guo YY; Siber GR
Vaccine; 1997; 15(6-7):672-8. PubMed ID: 9178469
[TBL] [Abstract][Full Text] [Related]
9. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
[TBL] [Abstract][Full Text] [Related]
10. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R
Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030
[TBL] [Abstract][Full Text] [Related]
11. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.
Tobío M; Nolley J; Guo Y; McIver J; Alonso MJ
Pharm Res; 1999 May; 16(5):682-8. PubMed ID: 10350011
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen.
Chang AC; Gupta RK
J Pharm Sci; 1996 Feb; 85(2):129-32. PubMed ID: 8683435
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
[TBL] [Abstract][Full Text] [Related]
14. Effect of polymer porosity on aqueous self-healing encapsulation of proteins in PLGA microspheres.
Reinhold SE; Schwendeman SP
Macromol Biosci; 2013 Dec; 13(12):1700-10. PubMed ID: 24285573
[TBL] [Abstract][Full Text] [Related]
15. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
16. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
[TBL] [Abstract][Full Text] [Related]
18. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
Johansen P; Corradin G; Merkle HP; Gander B
J Control Release; 1998 Dec; 56(1-3):209-17. PubMed ID: 9801444
[TBL] [Abstract][Full Text] [Related]
19. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit.
Mohaghegh M; Tafaghodi M
Pharm Dev Technol; 2011 Feb; 16(1):36-43. PubMed ID: 20082579
[TBL] [Abstract][Full Text] [Related]
20. Effect of Self-healing Encapsulation on the Initial Burst Release from PLGA Microspheres Containing a Long-Acting Prostacyclin Agonist, ONO-1301.
Hazekawa M; Kojima H; Haraguchi T; Yoshida M; Uchida T
Chem Pharm Bull (Tokyo); 2017; 65(7):653-659. PubMed ID: 28674339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
